2026-09-13 · 3 篇
鼻咽癌放疗后放射性第二原发恶性肿瘤的风险与预后生存分析：调强放疗与二维放疗的比较
Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy.
中文版接纳与承诺疗法综合评估量表在鼻咽癌患者中的信效度：一项横断面研究
The reliability and validity of the Chinese version of the comprehensive assessment of acceptance and commitment therapy processes in individuals with nasopharyngeal carcinoma: A cross-sectional study.
脂质体伊立替康联合尼妥珠单抗治疗免疫检查点抑制剂难治性复发或转移性鼻咽癌的疗效与安全性：一项单臂、开放标签、II期试验
Efficacy and safety of liposomal irinotecan plus nimotuzumab in immune checkpoint inhibitor-refractory recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase II trial.
2026-09-11 · 4 篇
美国社区层面脆弱性关联与早发和晚发鼻咽癌预后差异的研究
Differences of Community-Level Vulnerability Associations With Early- and Later-Onset Nasopharyngeal Cancer Prognosis in the United States.
治疗前EB病毒DNA不可检测的II-IVA期鼻咽癌患者的治疗与临床结局
Treatment and clinical outcomes among stage II-IVA nasopharyngeal carcinoma patients with undetectable pretreatment Epstein-Barr viral DNA.
原发与转移性鼻咽癌基因组及免疫差异的纵向分析：面向精准肿瘤学
Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology.
定量MRI在评估局部晚期鼻咽癌斜坡侵犯中的价值
Quantitative MRI in the assessment of clival invasion in locally advanced nasopharyngeal carcinoma.
2026-09-10 · 3 篇
局部治疗复发性/转移性病灶可增强鼻咽癌免疫检查点抑制剂的获益。
Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.
儿童及青少年局部晚期鼻咽癌诱导化疗方案的比较有效性：一项回顾性IPTW分析
Comparative Effectiveness of Induction Chemotherapy Regimens in Pediatric and Adolescent Locally Advanced Nasopharyngeal Carcinoma: A Retrospective IPTW Analysis.
复发性或持续性鼻咽癌的内镜下鼻咽切除术：香港某三级中心10年结局
Endoscopic nasopharyngectomy for recurrent or persistent nasopharyngeal carcinoma: a 10-year outcome from a tertiary centre in Hong Kong.
2026-09-09 · 1 篇
复发或转移性鼻咽癌抗PD-1治疗后BMI与代谢综合征和结局的预后关联
Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
2026-09-08 · 2 篇
治疗前MRI定义的坏死性淋巴结表型可识别N3期鼻咽癌远处转移风险的异质性
Pretreatment MRI-defined necrotic nodal phenotypes identify distant metastasis risk heterogeneity in N3 nasopharyngeal carcinoma.
三周方案与每周方案顺铂同步放化疗治疗鼻咽癌的疗效与毒性比较
Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma.